 |
49 Diseases |  |
1 Trial |
|
1 Trial |  |
170 News |  |
| «123 |
- | dextromethorphan hydrobromide/quinidine sulfate / Generic mfg.
New P2 trial: Clinical Trial Nuedexta in Subjects With ALS (clinicaltrials.gov) - Mar 5, 2013
P2, N=60, Recruiting, Sponsor: Center for Neurologic Study, La Jolla, California,
- ||||| dextromethorphan hydrobromide/quinidine sulfate / Generic mfg.
New P4 trial: PRISM II: Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA) (clinicaltrials.gov) - Feb 25, 2013
P4, N=750, Recruiting, Sponsor: Avanir Pharmaceuticals
- | deudextromethorphan/quinidine ultra-low dose (AVP-786) / Otsuka
New P1 trial: Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers (clinicaltrials.gov) - Feb 7, 2013
P1, N=48, Completed, Sponsor: Avanir Pharmaceuticals
- | dextromethorphan hydrobromide/quinidine sulfate / Generic mfg.
New P2 trial: Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (clinicaltrials.gov) - Jan 10, 2013
P2, N=16, Recruiting, Sponsor: Avanir Pharmaceuticals
- |||| dextromethorphan hydrobromide/quinidine sulfate / Generic mfg.
Enrollment open: Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease (clinicaltrials.gov) - Aug 29, 2012
P2, N=200, Recruiting, Sponsor: Avanir Pharmaceuticals
Not yet recruiting --> Recruiting
- dextromethorphan hydrobromide/quinidine sulfate / Generic mfg.
New P2 trial: Nuedexta for the Treatment of Adults With Autism (clinicaltrials.gov) - Jun 26, 2012
P2, N=20, Recruiting, Sponsor: Sutter Health
- ||||| dextromethorphan hydrobromide/quinidine sulfate / Generic mfg.
New P2 trial: Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease (clinicaltrials.gov) - Apr 23, 2012
P2, N=200, Recruiting, Sponsor: Avanir Pharmaceuticals